K-ras mutations, rectal crypt cells proliferation, and meat consumption in patients with left-sided colorectal carcinoma

被引:8
作者
O'Brien, H [1 ]
Matthew, JA [1 ]
Gee, JM [1 ]
Watson, M [1 ]
Rhodes, M [1 ]
Speakman, CTM [1 ]
Stebbings, WSL [1 ]
Kennedy, HJ [1 ]
Johnson, IT [1 ]
机构
[1] Inst Food Res, Norwich Lab, Norwich NR4 7UA, Norfolk, England
关键词
carcinoma; colorectal; crypt; diet; K-ras; proliferation;
D O I
10.1097/00008469-200002000-00006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It has been suggested that N-nitroso compounds derived from meat may increase the risk of K-ras mutations in the human colon, We sought evidence of associations between red meat consumption, frequency and type of K-ras mutations in resected tumours, and the rate of crypt cell proliferation (CCP) in the normal mucosa of patients with left-sided colorectal carcinoma. Meat consumption was assessed by food frequency questionnaire, and CCP was determined in rectal biopsies obtained prior to surgery, K-ras mutations in the resected tumours were determined using a PCR-based oligonucleotide hybridization assay. Fifteen K-ras mutations were detected in tumours from 43 patients; 13/15 in codon 12, 3/15 in codon 13, and 1/15 in both codons 12 and 13, All mutations were G --> A or G --> T transitions. There was no statistically significant difference between intakes of red meat in patients with a K-ras mutation (92.4 +/- 9.7 g/day) and those without (82.3 +/- 7.7 g/day), Rectal CCP was significantly higher in patients than in healthy controls, but there was no correlation with meat consumption or K-ras mutation. These data do not support the hypothesis that meat consumption is a risk factor for acquisition of K-ras mutations during colorectal carcinogenesis. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 37 条
  • [31] Determination of microsatellite instability, p53 and K-ras mutations in hepatic metastases from patients with colorectal cancer:: Relationship with response to 5-fluorouracil and survival
    Rosty, C
    Chazal, M
    Etienne, MC
    Letoublon, C
    Bourgeon, A
    Delpero, JR
    Pezet, D
    Beaune, P
    Laurent-Puig, P
    Milano, G
    INTERNATIONAL JOURNAL OF CANCER, 2001, 95 (03) : 162 - 167
  • [32] The Prognostic Value of c-Kit, K-ras Codon 12, and p53 Codon 72 Mutations in Egyptian Patients With Stage II Colorectal Cancer
    El-Serafi, Mostafa M.
    Bahnassy, Abeer A.
    Ali, Nasr M.
    Eid, Salem M.
    Kamel, Mahmoud M.
    Abdel-Hamid, Nayera A.
    Zekri, Abdel-Rahman N.
    CANCER, 2010, 116 (21) : 4954 - 4964
  • [33] Detection of K-ras point mutations in mesenteric venous blood from colorectal cancer patients by enriched polymerase chain reaction and single-strand conformation polymorphism analysis
    Fujita, S
    Sugano, K
    Fukayama, N
    Moriya, Y
    Sugihara, K
    Akasu, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1996, 26 (06) : 417 - 421
  • [34] Modified mismatch polymerase chain reaction-restriction fragment length polymorphism detected mutations in codon 12 and 13 of exon 2 of K-ras gene in colorectal cancer patients and its association with liver metastases: Data from a South Asian country
    Faleel, Fathima Dhilhani Mohamed
    De Zoysa, M. I. M.
    Lokuhetti, M. D. S.
    Gunawardena, Y. I. N. S.
    Chandrasekharan, Vishvanath Naduviladath
    Dassanayake, Ranil Samantha
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (04) : 1272 - 1277
  • [35] FOLFOX plus anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) is an effective first-line treatment for patients with RAS-wild left-sided metastatic colorectal cancer: A meta-analysis
    Chen, Datian
    Li, Li
    Zhang, Xiang
    Gao, Guangyi
    Shen, Lili
    Hu, Jing
    Yang, Mi
    Liu, Baorui
    Qian, Xiaoping
    MEDICINE, 2018, 97 (10)
  • [36] "Field cancerization" - An additional phenomenon in the development of colonic tumors? Mutations of the K-ras codon 12 in normal colonic mucosa from patients with colorectal neoplasia ["Field cancerization" - Ein zusätzliches Phänomen in der Entwicklung von Colontumoren? K-ras-Codon-12-Mutationen in normaler Colonmucosa von Patienten mit colorectalen Neoplasien *]
    Aivado M.
    Gynes M.
    Gorelov V.
    Schmidt W.U.
    Röher H.-D.
    Goretzki P.E.
    Der Chirurg, 2000, 71 (10): : 1230 - 1235
  • [37] Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNU-2 study
    Sastre, J.
    Garcia-Alfonso, P.
    Vieitez, J. M.
    Cano, M. T.
    Rivera, F.
    Reina-Zoilo, J. J.
    Salud-Salvia, A.
    Quintero, G.
    Robles-Diaz, L.
    Safont, M. J.
    La Casta, A.
    Gil, S.
    Polo, E.
    Asensio-Martinez, E.
    Garcia-Paredes, B.
    Lopez, R. L.
    Guillot, M.
    Valladares-Ayerbes, M.
    Aranda, E.
    Diaz-Rubio, E.
    ESMO OPEN, 2021, 6 (02)